Scrolling news:

Iraq: US seeks verification of ‘Islamic State’ beheading of journalist James Foley

Japan: Torrential rains unleash deadly landslide killing a dozen people in Hiroshima

Palestine: Three Palestinians killed, incl 3 year-old child, in Israeli airstrikes on Gaza City

Palestine: Dozens Palestinians abducted by Israeli forces in West Bank, Jerusalem

Palestine: Israeli army demolishes cave housing family near Bethlehem

Palestine: Several Palestinians kidnapped by Israeli forces in West Bank, Israeli settlers attack cars

Palestine: Israel bombs Gaza, withdraws negotiators from Cairo

Pakistan: 18 suspected militants killed in fresh NWA, Khyber airstrikes

US: Ferguson curfew lifted, Obama appeals for restraint

Iraq: Obama says Mosul Dam retaken from extremists with US help

Palestine: Palestinian female detainee denied family visits since her arrest in 2012

Palestine: Nine Palestinians kidnapped by Israeli soldiers from West Bank, Jerusalem

Palestine: Israeli army detonates two homes in Hebron, seals one with concrete blocs

Palestine: Six Palestinians kidnapped by Israeli forces in West Bank

Syria: Airstrikes kill 31 terrorists in Raqqa city

Palestine: Body recovered in Shujaiyya a month after ‘massacre’ by Israel

Palestine: Hamas says Israel stalling on agreement as Gaza death toll hits 2016

US: Curfew imposed for second night in Ferguson, Missouri

Palestine: Palestinian arrested filming Israeli settlers throwing stones in W Bank

Israel: 5 of 64 Israeli soldiers killed in Gaza invasion were killed by ‘Friendly Fire’

US: Firms cannot patent human genes, US court rules

14th Jun 2013

The US Supreme Court has ruled against patents for extracted human DNA, though synthesized genetic strains remain eligible. The court ruled that isolating naturally occurring material did not satisfy patent requirements.

In a unanimous vote on Thursday, the US Supreme Court in Washington ruled that human DNA came from nature and was therefore not eligible for patenting.

“A naturally occurring DNA segment is a product of nature and not patent-eligible merely because it has been isolated,” the court stated.

The nine justices struck down patents held by Myriad Genetics on two genes – BCRA1 and BCRA2 – linked to increased risk of breast and ovarian cancer. Having isolated, but in no way altered, the genes, Myriad Genetics had applied for exclusive rights to the strands – winning the case in lower courts.

In the previous cases, now overturned, judges had said that the isolated DNA had a “markedly different chemical structure” from that found in healthy bodies.

Thursday’s ruling pleased opponents who had been saying all along that patent protection shouldn’t be given to something that can be found inside the human body.

The US Supreme Court offered a compromise ruling in so far as reasoning that synthetically produced genetic material, also known as cDNA could after all be patented, because it was not naturally occurring and hence merited full legal protection.

“cDNA is patent-eligible because it is not naturally occurring,” the Supreme Court ruling said, going on to say that Myriad’s isolation of particular genes did not satisfy a requirement to claim a “new and useful … composition of matter” needed to secure a patent. “Myriad did not create or alter either the information encoded in the BCRA1 and BCRA2 genes or the genetic structure of the DNA. It found an important and useful gene, but groundbreaking, innovative, or even brilliant discovery does not by itself satisfy the… inquiry.”

hg/msh (Reuters, AP, AFP)


Comments are closed.

The Muslim News Awards for Excellence event is to acknowledge British Muslim and non-Muslim contributions to society. Over 850 people from diverse background, Muslim and non-Muslim, attended the gala dinner.

Latest Tweets

The Muslim News


Awards for Excellence

Read more